Czech National Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Buy
502,897
+21,557
+4% +$4.64M 0.69% 24
2026
Q1
$105M Buy
481,340
+15,308
+3% +$3.4M 0.69% 21
2025
Q4
$106M Buy
466,032
+17,373
+4% +$3.96M 0.69% 19
2025
Q3
$104M Buy
448,659
+16,888
+4% +$3.44M 0.72% 22
2025
Q2
$80.1M Buy
431,771
+26,296
+6% +$4.89M 0.62% 23
2025
Q1
$85M Buy
405,475
+22,324
+6% +$4.34M 0.78% 22
2024
Q4
$68.1M Buy
383,151
+23,328
+6% +$4.29M 0.63% 24
2024
Q3
$71.1M Buy
359,823
+23,320
+7% +$4.35M 0.72% 22
2024
Q2
$57.7M Buy
336,503
+25,855
+8% +$4.28M 0.66% 22
2024
Q1
$56.6M Buy
310,648
+1,373
+0.4% +$237K 0.73% 22
2023
Q4
$47.9M Buy
309,275
+780
+0.3% +$114K 0.68% 22
2023
Q3
$46M Buy
308,495
+99,639
+48% +$14.6M 0.73% 21
2023
Q2
$28.1M Buy
208,856
+520
+0.2% +$76.3K 0.64% 24
2023
Q1
$33.2M Buy
208,336
+1,238
+0.6% +$189K 0.82% 19
2022
Q4
$33.5M Buy
207,098
+1,714
+0.8% +$263K 0.89% 20
2022
Q3
$27.6M Buy
+205,384
New +$29.5M 0.79% 21

Other funds holding ABBV

Czech National Bank's ABBV Position: Q2 2026 in Review

Czech National Bank increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $4.64M and bringing the position to 502,897 shares worth $127M. The position accounts for 0.69% of the portfolio, ranked #24.

Czech National Bank first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Czech National Bank held 502,897 shares of AbbVie worth $127M as of Q2 2026.
  • Czech National Bank bought 21,557 AbbVie shares in Q2 2026, an estimated $4.64M.
  • AbbVie made up 0.69% of Czech National Bank's portfolio in Q2 2026, its #24 holding.
  • Czech National Bank first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.